VA SAN diego pharmacy service is requesting a sole source procurement from alliancerx walgreens specialty pharmacy, a sole distributor for tolvaptan (jynarque
Ended Awarded Last action
- Contract number
- 36C26223F0028
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $168,748
Award facts
- Contract value 93% obligated
- $180,972.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$12,225 | |
| Supplemental Agreement for work within scope | $43,864 | |
| Original award | $137,108 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a delivery order valued at $180,972.27 to Otsuka America Pharmaceutical Inc. for the supply of Jynarque (tolvaptan) through a sole source procurement on October 20, 2022. Jynarque is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. This delivery order, issued under a firm fixed-price arrangement with an ultimate completion date of September 30, 2023, represents one of multiple task orders executed against the company's broader Federal Supply Schedule contract for pharmaceuticals and drugs (FSS-61-IB). The performance location is designated as Pittsburgh, PA 15275.
This award is supported by Otsuka America Pharmaceutical Inc.'s significant indefinite delivery vehicles with the VA, including an $83.3 million Blanket Purchase Agreement for Jynarque issued by the National Acquisition Center and a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. No set-aside designation was utilized for this procurement, reflecting the contractor's established status as a large pharmaceutical manufacturer with demonstrated capability to serve the VA's specialized healthcare requirements across multiple Veterans Integrated Service Networks. The delivery order supports the VA's mission to provide critical pharmaceutical treatments to veterans nationwide.
Quick answers
Who was awarded contract 36C26223F0028?
36C26223F0028 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 20, 2022.
How much is contract 36C26223F0028 worth?
The government has obligated $168,748 on 36C26223F0028. Its current value, with exercised options, is $180,972.
Is contract 36C26223F0028 an order under another contract?
Yes. 36C26223F0028 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26223F0028 competed?
The extent of competition for 36C26223F0028 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award